drugset / Trial / NCT06035393
A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double blind, double dummy, active-controlled, parallel-group study to assess the efficacy and Safety of HRG2005 inhalation in patients with moderate to severe chronic obstructive pulmonary disease. Approximately 200 patients with moderate to severe COPD will be randomized into the study.
Timeline
- Start
- 2024-01-15
- Primary completion
- 2025-02-17
- Completion
- 2025-02-17
Outcome
Outcome not reported
Stopped (Business): “Sponsor's R\&D strategy adjusted.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrronium | Unknown | — | Inhaled |
| Subject | HRG2005 | Unknown | — | Inhaled |
| Subject | Indacaterol | Other / unclassified | — | Inhaled |